Assessment of Risk Evaluation and Mitigation Strategies (REMS) for varenicline (Chantix): A multistage patient survey
ConclusionsA large majority of patients who were dispensed varenicline recalled receiving the MG and were able to correctly recall neuropsychiatric and cardiovascular risks in all 3 surveys. The varenicline MG may be an effective tool for patient education.
Source: Pharmacoepidemiology and Drug Safety - Category: Drugs & Pharmacology Authors: Kandace L. Amend, Muhammad Younus, Kenneth R. Petronis, Jingping Mo, John D. Seeger, Robert Gately, Xiangmei Gu, Cheryl Enger Tags: ORIGINAL REPORT Source Type: research
More News: Allergy & Immunology | Brain | Cardiology | Cardiovascular | Chantix | Drugs & Pharmacology | Education | Heart | Neurology | Skin | Universities & Medical Training